Geneva: The World Health Organization (WHO) accepted the recommendation from the Solidarity Trial’s International Steering Committee on Saturday, to discontinue the trials of hydroxychloroquine (HCQ) and lopinavir/ritonavir arms.
According to a press release, citing little or no reduction in the mortality rate of the hospitalised COVID-19 patients, WHO reportedly said, the decision was in light of the evidence from the Solidarity Trial’s interim results.
“These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized Covid-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect,” Xinhua reported WHO’s release.
The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for patients already admitted to hospitals.
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
Balasore: With the festival of Maha Shivratri fast approaching, hectic preparations are underway at the… Read More
New Delhi: In a recent social media post, actress Kangana Ranaut sparked controversy by defending… Read More
Dubai: India restricted Pakistani to a manageable total in their Group A Champions Trophy clash,… Read More
Bhubaneswar: Hundreds of turtles being transported illegally were seized from a vehicle in Godipada area… Read More
This website uses cookies.
